2024-05-14 19:08:02 ET
BioRestorative Therapies, Inc. (BRTX)
Q1 2024 Earnings Conference Call
May 14, 2024, 04:30 PM ET
Company Participants
Stephen Kilmer - Head of Investor Relations
Lance Alstodt - President, Chief Executive Officer and Chairman of the Board
Robert Kristal - Chief Financial Officer
Francisco Silva - Vice President of Research and Development
Conference Call Participants
Michael Okunewitch - the Maxim Group
Jonathan Aschoff - ROTH MKM
Presentation
Operator
Good afternoon, everyone, and welcome to the BioRestorative Therapies Q1 Business Update Conference Call. At this time, all participants are in a listen-only mode, and we will open for questions following the presentation. [Operator Instructions] Please note this conference is being recorded.
I will now turn the conference over to your host, Steve Kilmer, investor Relations. Steve, the floor is yours.
Stephen Kilmer
Thank you, Jenny. Good afternoon, everyone. Let me start by pointing out that this conference call will include forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking statements are based on BioRestorative's current beliefs, assumptions, and expectations, and such statements involve known and unknown risks, uncertainties, and other factors that may cause actual results, performance, or achievements to be materially different from those implied by such statements. No forward-looking statement can be guaranteed....
Read the full article on Seeking Alpha
For further details see:
BioRestorative Therapies, Inc. (BRTX) Q1 2024 Earnings Call Transcript